Advanced Therapy Medicinal Products (ATMPs) have emerged as groundbreaking treatments for challenging diseases, encompassing cell therapies, gene editing technologies, and mRNA therapeutics. Despite their transformative potential, the accessibility of these innovative medicinal products is hindered by significant manufacturing challenges, including high costs and regulatory concerns. This presentation delves into the critical issues impeding patient access to ATMPs and explores the future landscape of ATMP manufacturing. Emphasizing the urgency of addressing these challenges, we discuss innovative approaches, particularly the shift toward decentralized manufacturing. The presentation also sheds light on current trends shaping the ATMP production landscape, covering advancements in modalities, technologies, Turnkey Solutions, and the integration of Industry 4.0 tools. Join us as we unravel the key solutions poised to shape the future of launching ATMPs, making them more accessible, efficient, and impactful in the realm of modern medicine.